Bio-Techne (TECH) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.30% |
| Dec 31, 2025 | -0.46% |
| Sep 30, 2025 | 136.54% |
| Jun 30, 2025 | -562.60% |
| Mar 31, 2025 | -35.26% |
| Dec 31, 2024 | 3.84% |
| Sep 30, 2024 | 421.35% |
| Jun 30, 2024 | -121.31% |
| Mar 31, 2024 | 78.62% |
| Dec 31, 2023 | -46.14% |
| Sep 30, 2023 | 11.62% |
| Jun 30, 2023 | -34.94% |
| Mar 31, 2023 | 40.42% |
| Dec 31, 2022 | -44.27% |
| Sep 30, 2022 | 44.93% |
| Jun 30, 2022 | 2.94% |
| Mar 31, 2022 | -16.54% |
| Dec 31, 2021 | 4.46% |
| Sep 30, 2021 | 204.70% |
| Jun 30, 2021 | -245.11% |
| Mar 31, 2021 | -1.61% |
| Dec 31, 2020 | 38.18% |
| Sep 30, 2020 | -53.91% |
| Jun 30, 2020 | 98.87% |
| Mar 31, 2020 | -69.54% |
| Dec 31, 2019 | 730.82% |
| Sep 30, 2019 | -12.53% |
| Jun 30, 2019 | -63.14% |
| Mar 31, 2019 | 154.35% |
| Dec 31, 2018 | 0.88% |
| Sep 30, 2018 | 143.66% |
| Jun 30, 2018 | -301.93% |
| Mar 31, 2018 | -59.59% |
| Dec 31, 2017 | 208.12% |
| Sep 30, 2017 | -42.58% |
| Jun 30, 2017 | 24.55% |
| Mar 31, 2017 | 196.87% |
| Dec 31, 2016 | -60.35% |
| Sep 30, 2016 | 566.32% |
| Jun 30, 2016 | -113.33% |
| Mar 31, 2016 | 17.18% |
| Dec 31, 2015 | 13.84% |
| Sep 30, 2015 | -23.43% |
| Jun 30, 2015 | 22.09% |
| Mar 31, 2015 | -26.86% |
| Dec 31, 2014 | 38.91% |
| Sep 30, 2014 | 123.70% |
| Jun 30, 2014 | -418.75% |
| Mar 31, 2014 | 26.29% |
| Dec 31, 2013 | -8.65% |
| Sep 30, 2013 | -58.29% |
| Jun 30, 2013 | 98.54% |
| Mar 31, 2013 | 30.57% |
| Dec 31, 2012 | -1.18% |
| Sep 30, 2012 | -5.77% |
| Jun 30, 2012 | -14.22% |
| Mar 31, 2012 | 23.02% |
| Dec 31, 2011 | -6.21% |
| Sep 30, 2011 | 126.78% |
| Jun 30, 2011 | -430.77% |
| Mar 31, 2011 | 17.07% |
| Dec 31, 2010 | 0.61% |
| Sep 30, 2010 | 129.50% |
| Jun 30, 2010 | -376.01% |
| Mar 31, 2010 | 31.01% |
| Dec 31, 2009 | -7.66% |